Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Poxvirus vectors for gene transfer]

M Kawakita1, O Yoshida, T L Ratliff

  • 1Department of Urology, Faculty of Medicine, Kyoto University.

Hinyokika Kiyo. Acta Urologica Japonica
|January 22, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Automatic color-temperature compensator with guest-host liquid-crystal filter for video image sensing.

Applied optics·2008
Same author

Axi-vision camera (real-time distance-mapping camera).

Applied optics·2008
Same author

Spatial light modulators for high-brightness projection displays.

Applied optics·2008
Same author

Urine diacetylspermine as a novel tumour maker for pancreatobiliary carcinomas.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·2005
Same author

Radical retropubic prostatectomy: time trends, morbidity and mortality in Japan.

Prostate cancer and prostatic diseases·2002
Same author

UDP-sugar transporter implicated in glycosylation and processing of Notch.

Nature cell biology·2001

Modified tumor cells carrying cytokine genes, like interleukin 2, show promise for cancer immunotherapy. Poxvirus vectors effectively deliver these genes, inhibiting tumor growth and protecting against subsequent tumor challenges.

Area of Science:

  • Oncology
  • Immunology
  • Virology

Background:

  • Cancer immunotherapy utilizes modified tumor cells to enhance anti-tumor immune responses.
  • Cytokine and costimulatory molecule gene delivery can augment anti-cancer immunity.

Purpose of the Study:

  • To evaluate the efficacy of poxvirus vectors for delivering cytokine and immunomodulatory genes into tumor cells for cancer immunotherapy.
  • To assess the impact of local cytokine production on tumor growth and host immune protection.

Main Methods:

  • Incorporation of cytokine genes (tumor necrosis factor-alpha, interleukin 2, interferon gamma) and B7-1 into canarypox virus (ALVAC) and vaccinia virus (NYVAC) vectors.
  • Infection of mouse tumor cell lines (RM-1 and MBT-2) with engineered poxvirus vectors.
  • Assessment of tumor growth inhibition and protective immunity in tumor-bearing mice.

Related Experiment Videos

Main Results:

  • Poxvirus vectors efficiently expressed high levels of cytokines and B7-1.
  • Infection with these vectors significantly inhibited the growth of RM-1 and MBT-2 tumors.
  • Mice immunized with ALVAC-interleukin 2-infected tumor cells were protected from subsequent tumor challenge.

Conclusions:

  • Poxvirus vectors are effective and safe tools for gene delivery in cancer immunotherapy.
  • Local cytokine production via poxvirus vectors can inhibit tumor growth and induce protective immunity.
  • This approach holds potential for developing novel cancer vaccines and immunotherapies.